Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Arsenic, R."'
Autor:
Felder, S., Jann, H., Arsenic, R., Denecke, T., Prasad, V., Knappe-Drzikova, B., Maasberg, S., Wiedenmann, B., Pavel, M., Pascher, A., Pape, U. F.
Publikováno v:
Endocrine-Related Cancer; Sep2019, Vol. 26 Issue 9, p751-763, 13p
Autor:
Pape, U.-F., Kasper, S., Meiler, J., Sinn, M., Vogel, A., Mueller, L., Burkhard, O., Caca, K., Heeg, S., Rodriguez Laval, V., Kuhl, A.A., Arsenic, R., Jansen, H., Mehrling, T., Hilgier, K., Wagner, I., Utku, N.
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v278-v278
Autor:
Hillebrandt, K. H., Arsenic, R., Hofmann, J., Eurich, D., Gül, S., Strücker, B., Sauer, I. M., Pratschke, J., Stockmann, M., Raschzok, Nathanael
Publikováno v:
Experimental & Clinical Transplantation; Jun2018, Vol. 16 Issue 3, p348-351, 4p
Autor:
von Laffert, M., Elezkurtaj, S., Sehouli, J., Barinoff, J., Boschetti Grützmacher, E., Arsenic, R., Bläker, H.
Publikováno v:
Der Pathologe; May2018, Vol. 39 Issue 3, p264-268, 5p
Autor:
Wang J, Seeberger MD, Skarvan K, Michaux I, Bernet F, Arsenic R, Buser P, Filipovic M, Wang, J, Seeberger, M D, Skarvan, K, Michaux, I, Bernet, F, Arsenic, R, Buser, P, Filipovic, M
Publikováno v:
European Journal of Anaesthesiology (Cambridge University Press); Jan2008, Vol. 25 Issue 1, p1-7, 7p
Publikováno v:
Der Pathologe; Jul2014, Vol. 35 Issue 4, p379-382, 4p
Publikováno v:
Scopus-Elsevier
Background: Malignant vaginal melanoma is extremely rare and accounts for fewer than 0.3% of all melanomas in women. Amelanotic malignant melanoma is a subtype of melanoma with little or no pigment on visual inspection. The simultaneous occurrence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::93838697c4a6283141e198e7cfcb0d54
http://www.scopus.com/inward/record.url?eid=2-s2.0-84861497634&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84861497634&partnerID=MN8TOARS
Autor:
Filipovic, M., Probst, C., Arsenic, R., Werner, C., Seeberger, E., Jeger, R., Seeberger, M. D.
Publikováno v:
European Journal of Anaesthesiology Supplement; 2002 Supplement, Vol. 19 Issue S27, p31-31, 1p
Autor:
Valentina Andreasi, Andreas Pascher, Felix J. Krendl, Claudio Doglioni, Stefano Partelli, Bertram Wiedenmann, Ruza Arsenic, Marianne Pavel, Stefan Staettner, Thomas M. Gress, Daniel Kaemmerer, Anja Rinke, Massimo Falconi, Elettra Merola
Background Stage IV gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) G3 are the NENs with the worst prognosis. According to ENETS guidelines, platinum-based chemotherapy is the standard treatment for this population. Surgery is only consi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936cd693e5ce65b116f103357b81e9dd
Autor:
Valentina Andreasi, Attila Kollár, Birgit Cremer, Francesco Panzuto, Daniel Kaemmerer, Henning Jann, Anja Rinke, Aurel Perren, Abbas Agaimy, Massimo Falconi, Elettra Merola, Rainer W. Lipp, Emanuel Christ, Patrizia Kump, Ruza Arsenic, Stefano Partelli, Thomas M. Gress, Marianne Pavel, Bertram Wiedenmann, Andreas Pascher
Background: While platinum-based chemotherapy represents the standard treatment for advanced grade 3 (G3) neuroendocrine neoplasms (NENs) according to the European Neuroendocrine Tumor Society guidelines, the role of radical-intended surgery in these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a56dd895fdc71b72d7a1a2e26cd9227d